Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anemia as a risk factor and therapeutic target in heart failure.
Felker GM, Adams KF Jr, Gattis WA, O'Connor CM. Felker GM, et al. Among authors: gattis wa. J Am Coll Cardiol. 2004 Sep 1;44(5):959-66. doi: 10.1016/j.jacc.2004.05.070. J Am Coll Cardiol. 2004. PMID: 15337204 Free article. Review.
Vasopressin: a new target for the treatment of heart failure.
Lee CR, Watkins ML, Patterson JH, Gattis W, O'connor CM, Gheorghiade M, Adams KF Jr. Lee CR, et al. Am Heart J. 2003 Jul;146(1):9-18. doi: 10.1016/S0002-8703(02)94708-3. Am Heart J. 2003. PMID: 12851603 Review.
Which beta-blocker for heart failure?
Patel MR, Gattis W. Patel MR, et al. Am Heart J. 2004 Feb;147(2):238. doi: 10.1016/j.ahj.2003.12.021. Am Heart J. 2004. PMID: 14760319 No abstract available.
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M; IMPACT-HF Investigators and Coordinators. Gattis WA, et al. J Am Coll Cardiol. 2004 May 5;43(9):1534-41. doi: 10.1016/j.jacc.2003.12.040. J Am Coll Cardiol. 2004. PMID: 15120808 Free article. Clinical Trial.
58 results